OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance
Zhenzhen Chen, Youyou Yan, Chao Qi, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 32
Zhenzhen Chen, Youyou Yan, Chao Qi, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Iron overload‐induced ferroptosis of osteoblasts inhibits osteogenesis and promotes osteoporosis: An in vitro and in vivo study
Zengxin Jiang, Hao Wang, Guobin Qi, et al.
IUBMB Life (2022) Vol. 74, Iss. 11, pp. 1052-1069
Closed Access | Times Cited: 78
Zengxin Jiang, Hao Wang, Guobin Qi, et al.
IUBMB Life (2022) Vol. 74, Iss. 11, pp. 1052-1069
Closed Access | Times Cited: 78
Suppression of lncRNA Gm47283 attenuates myocardial infarction via miR-706/ Ptgs2/ferroptosis axis
Feng Gao, Yongcheng Zhao, Bin Zhang, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 10786-10802
Open Access | Times Cited: 42
Feng Gao, Yongcheng Zhao, Bin Zhang, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 10786-10802
Open Access | Times Cited: 42
PGAM5 expression levels in heart failure and protection ROS-induced oxidative stress and ferroptosis by Keap1/Nrf2
Shuangfei Li, Ping Wen, Da‐Yong Zhang, et al.
Clinical and Experimental Hypertension (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 29
Shuangfei Li, Ping Wen, Da‐Yong Zhang, et al.
Clinical and Experimental Hypertension (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 29
Ferroptosis in cardiovascular disease
Guoqing Liu, Xiaoyong Xie, Wang Liao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116057-116057
Open Access | Times Cited: 26
Guoqing Liu, Xiaoyong Xie, Wang Liao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116057-116057
Open Access | Times Cited: 26
Ferroptosis: A double-edged sword
Shengmei Wang, Qiuyan Guo, Lili Zhou, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Shengmei Wang, Qiuyan Guo, Lili Zhou, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Dioscin pretreatment ameliorates ferroptosis in cardiomyocytes after myocardial infarction via inhibiting endoplasmic reticulum stress
Chang Wu, X. Shen, Pan Lou, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Chang Wu, X. Shen, Pan Lou, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
NMDARs activation regulates endothelial ferroptosis via the PP2A-AMPK-HMGB1 axis
Weimin Han, Yi‐Xiang Hong, G Xiao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Weimin Han, Yi‐Xiang Hong, G Xiao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway
Xi‐Ding Yang, Rongrong Deng, Daxiong Xiang
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1499-1514
Open Access | Times Cited: 7
Xi‐Ding Yang, Rongrong Deng, Daxiong Xiang
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1499-1514
Open Access | Times Cited: 7
Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
Zuoxiang Wang, Qingyue Xia, Wenxing Su, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 27
Zuoxiang Wang, Qingyue Xia, Wenxing Su, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 27
Ferroptosis: Emerging Role in Diseases and Potential Implication of Bioactive Compounds
Giuseppe Tancredi Patanè, Stefano Putaggio, Ester Tellone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17279-17279
Open Access | Times Cited: 16
Giuseppe Tancredi Patanè, Stefano Putaggio, Ester Tellone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17279-17279
Open Access | Times Cited: 16
Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors
Yansheng Yao, Peng Ji, Hao Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Yansheng Yao, Peng Ji, Hao Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping
Enrico Maiorino, Joseph Loscalzo
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 12
Enrico Maiorino, Joseph Loscalzo
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 12
The role of ferroptosis in cardio-oncology
Kai Hou, Lin Liu, Zhihui Fang, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 709-734
Closed Access | Times Cited: 4
Kai Hou, Lin Liu, Zhihui Fang, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 709-734
Closed Access | Times Cited: 4
Potential intervention target of atherosclerosis: Ferroptosis (Review)
Jia Li, Ling Xu, Yi Zuo, et al.
Molecular Medicine Reports (2022) Vol. 26, Iss. 5
Open Access | Times Cited: 17
Jia Li, Ling Xu, Yi Zuo, et al.
Molecular Medicine Reports (2022) Vol. 26, Iss. 5
Open Access | Times Cited: 17
Ferroptosis: a new strategy for cardiovascular disease
Yuyuan Wang, Junduo Wu
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 10
Yuyuan Wang, Junduo Wu
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 10
Noncoding RNAs regulating ferroptosis in cardiovascular diseases: novel roles and therapeutic strategies
Changyong Wu, Suli Bao, Huang Sun, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 11, pp. 2827-2841
Open Access | Times Cited: 9
Changyong Wu, Suli Bao, Huang Sun, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 11, pp. 2827-2841
Open Access | Times Cited: 9
Molecular mechanisms of ferroptosis in cardiovascular disease
Qun Zeng, Tingting Jiang
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3181-3193
Closed Access | Times Cited: 3
Qun Zeng, Tingting Jiang
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3181-3193
Closed Access | Times Cited: 3
Curdione inhibits ferroptosis in isoprenaline‐induced myocardial infarction via regulating Keap1 /Trx1 /GPX4 signaling pathway
Huihui Wang, Bao‐Ping Xie, Shuotao Shi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5328-5340
Open Access | Times Cited: 7
Huihui Wang, Bao‐Ping Xie, Shuotao Shi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5328-5340
Open Access | Times Cited: 7
Breast cancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasis
Tobias Ackermann, Engy Shokry, Ruhi Deshmukh, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 11, pp. 2749-2774
Closed Access | Times Cited: 2
Tobias Ackermann, Engy Shokry, Ruhi Deshmukh, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 11, pp. 2749-2774
Closed Access | Times Cited: 2
The ABA/LANCL1-2 Hormone Receptors System Controls ROS Production in Cardiomyocytes through ERRα
Sonia Spinelli, Lucrezia Guida, Mario Passalacqua, et al.
(2024)
Open Access | Times Cited: 2
Sonia Spinelli, Lucrezia Guida, Mario Passalacqua, et al.
(2024)
Open Access | Times Cited: 2
Research progress on the role of ferroptosis in cardiovascular disease
Han Li, Li Lin, Yunlong Xia, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Han Li, Li Lin, Yunlong Xia, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Synthesis and in vivo evaluation of new steviol derivatives that protect against cardiomyopathy by inhibiting ferroptosis
Chao Xu, E Ou, Zhiyin Li, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106142-106142
Closed Access | Times Cited: 8
Chao Xu, E Ou, Zhiyin Li, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106142-106142
Closed Access | Times Cited: 8
The Chains of Ferroptosis Interact in the Whole Progression of Atherosclerosis
Xueqi Wan, Huan Zhang, Jinfan Tian, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 4575-4592
Open Access | Times Cited: 4
Xueqi Wan, Huan Zhang, Jinfan Tian, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 4575-4592
Open Access | Times Cited: 4
The Vasodilator Effect and Mechanism of 18β-glycyrrhetinic Acid on Isolated Pulmonary Artery Rings in Rats
Huijuan Yang, Xiaojun Liu, Yuxin Liu, et al.
Pharmacognosy Magazine (2024) Vol. 20, Iss. 3, pp. 996-1004
Open Access | Times Cited: 1
Huijuan Yang, Xiaojun Liu, Yuxin Liu, et al.
Pharmacognosy Magazine (2024) Vol. 20, Iss. 3, pp. 996-1004
Open Access | Times Cited: 1
MMP9 Drives Ferroptosis by Regulating GPX4 and Iron Signaling
Flobater I. Gawargi, Paras K. Mishra
iScience (2024) Vol. 27, Iss. 9, pp. 110622-110622
Open Access | Times Cited: 1
Flobater I. Gawargi, Paras K. Mishra
iScience (2024) Vol. 27, Iss. 9, pp. 110622-110622
Open Access | Times Cited: 1
